Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel 5-HT2C receptor agonist developed at Lilly

June 6, 2005

Ferring submits IND for female infertility product

June 6, 2005

New data on the effects of TH-9507 in COPD

June 6, 2005

New data on the benefits of alprostadil in women with FSAD

June 6, 2005

Canadian approval of Glumetza for type 2 diabetes

June 3, 2005

Arena tests a new 5-HT2C receptor agonist for obesity treatment

June 3, 2005

FDA approval for Naglazyme

June 2, 2005

Recent patents describe novel treatments for osteoporosis

June 2, 2005

IND approval for cholesterol drug MAHDL-01

June 2, 2005

Titrated pramlintide benefits patients with type 1 diabetes

June 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...